Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

M. G. Kirby, G. Schnetzler, K.H. Zou, T. Symonds

Open source

DOI
10.1111/j.1742-1241.2011.02693.x
Published
2011-06-16
Container
International Journal of Clinical Practice
Publisher
Hindawi Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1742-1241.2011.02693.x,
  title = {Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study},
  author = {M. G. Kirby and G. Schnetzler and K.H. Zou and T. Symonds},
  year = {2011},
  journal = {International Journal of Clinical Practice},
  doi = {10.1111/j.1742-1241.2011.02693.x},
  url = {https://doi.org/10.1111/j.1742-1241.2011.02693.x}
}

RIS

TY  - JOUR
TI  - Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study
AU  - M. G. Kirby
AU  - G. Schnetzler
AU  - K.H. Zou
AU  - T. Symonds
PY  - 2011
JO  - International Journal of Clinical Practice
DO  - 10.1111/j.1742-1241.2011.02693.x
UR  - https://doi.org/10.1111/j.1742-1241.2011.02693.x
ER  - 

APA

Kirby, M. G., Schnetzler, G., Zou, K., & Symonds, T. (2011). Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. International Journal of Clinical Practice. https://doi.org/10.1111/j.1742-1241.2011.02693.x

Source records